Lumenis Announces New Global VP of Research and Development
11 December 2003 - 10:00AM
PR Newswire (US)
Lumenis Announces New Global VP of Research and Development
YOKNEAM, Israel, Dec. 10 /PRNewswire-FirstCall/ -- Lumenis Ltd. has
announced today that Mr. Igor Gradov has joined Lumenis as the
Global Vice President of Research & Development. "I am
extremely pleased to welcome Igor to our team, in a position which
I view as a key strategic position in our company's future. Having
a seasoned executive such as Igor, with 25 years of successfully
managing multi-disciplinary and international engineering and
scientific teams is a great asset to us and to our customers, that
expect us to continue to be leaders in our markets," stated Mr.
Avner Raz, President and Chief Executive Officer. Mr. Gradov has
spent his career dedicated to the design, development and product
introduction of light based medical products and technologies in
the market segments of Dermatology, Ophthalmology, Dentistry and
General Surgery. Mr. Gradov previously held positions as Director
of Engineering at Coherent Optical Division, Director of Research
& Development at VISX Inc., Vice President of Engineering for
Palomar Medical Technologies, Vice President Technology Development
at Emory Vision Correction Group, and most recently as COO of
Luxano AB, Sweden. About Lumenis Lumenis develops, manufactures,
and markets state-of-the-art proprietary laser and intense pulsed
light devices. Its systems are used in a variety of aesthetic,
ophthalmic, surgical and dental applications, including skin
treatments, hair removal, non-invasive treatment of vascular
lesions and pigmented lesions, acne, psoriasis, ENT, gynecology,
urinary lithotripsy, benign prostatic hyperplasia, open angle
glaucoma, diabetic retinopathy, secondary cataracts, age-related
macular degeneration, vision correction, neurosurgery, dentistry
and veterinary. For more information about the Company and its
products log on to http://www.lumenis.com/ The statements in this
press release that are not historical facts are forward-looking
statements which are subject to risks and uncertainties. The
Company's actual results could differ materially from those
anticipated in the forward looking statements based on a variety of
factors, including, among others: uncertainties with respect to
market acceptance of the Company's products, obtaining regulatory
approvals for new products or for the sale of existing products in
new markets and enforcement of intellectual property rights; risks
associated with competition and competitive pricing pressures,
economic conditions generally, the Company's international
operations and the Company's ability to integrate its operations
with those of acquired businesses; the outcome of the Securities
and Exchange Commission investigation and several securities class
action lawsuits to which the Company is subject; uncertainties
relating to the Company's continuing liquidity; and other risks
detailed from time to time in the reports filed by Lumenis with the
SEC, including its annual report on Form 10-K and quarterly reports
on Form 10-Q. Contacts: Kevin Morano CFO 212-515-4187 DATASOURCE:
Lumenis Ltd. CONTACT: Kevin Morano, CFO of Lumenis Ltd.,
+1-212-515-4187 Web Site: http://www.lumenis.com/
Copyright
Lumenis (NASDAQ:LUMEE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Lumenis (NASDAQ:LUMEE)
Historical Stock Chart
From Sep 2023 to Sep 2024
Real-Time news about Lumenis Ltd. (MM) (NASDAQ): 0 recent articles
More Lumenis Ltd. (MM) News Articles